59
Views
27
CrossRef citations to date
0
Altmetric
Miscellaneous

Recent developments in cationic lipid-mediated gene delivery and gene therapy

&
Pages 1729-1752 | Published online: 25 Feb 2005

Bibliography

  • LANDER ES, LINTON LM, BIRREN B,NUSBAUM C: Initial sequencing andanalysis of the human genome. Nature (2001) 409:860–921.
  • VENTER JC, ADAMS MD, MYERS EW et al.: The sequence of the human genome. Science (2001) 291:1304–1351.
  • Gene Therapy: Lemoine NR, Cooper DN (Eds.), Oxford, BIOS Scientific Publishers, (1996).
  • Gene Therapy. Therapeutical Mechanisms and Strategies: Templeton NS, Lasic DD (Eds.), New York, Basel, Marcel Dekker, (2000).
  • FRIEDMANN T: Gene Therapy: Delivering the Medicines of the 21st Century. Nat. Med. (1996) 2:144–147.
  • SCHERMAN D, BESSODES M, CAMERON B et al.: Application of lipids and plasmid design for gene delivery tomammalian cells. Curr. Opin. Biotechnol (1998) 9:480–485.
  • MOUNTAIN A: Gene therapy: the firstdecade. Trends Biotechnol. (2000) 18:119–128.
  • BEHR JP: Synthetic gene-transfer vectors. Am. Chem. Res. (1993) 26:274–278.
  • DESHMUKH HM, HUANG L: Liposome 1744Expert Op/n. Ther. Patents (2001) 11(11) and polylysine mediated gene transfer. New Chem. (1997) 21:113–124.
  • WOLFF JA, TRUBETSKOY VS: The Cambrian period of nonviral gene delivery. Nat. Biotechnol. (1998) 16:421–422.
  • ANGELOVA MI, HRISTOVA N, TSONEVA I: DNA-induced endocytosis upon local microinjection to giant unilamellar cationic vesicles. Eur. Biophys. (1999) 28:142–150.
  • HENGGE UR, TAICHMAN LB, KAUR P et al.: How realistic is cutaneous gene therapy? Exp. Dermatol. (1999) 8:419–431.
  • WEAVER JC: Electroporation: a general phenomenon for manipulating cells and tissues. j Cell Biochem. (1993) 51:426–435.
  • ZHANG L, LI L, HOFFMANN GA, HOFFMAN RIVI: Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin aging and other diseases. Biochem. Biophys. Res. Commun. (1996) 220:633–636.
  • JAROSZESKI MJ, GILBERT R, NICOLAU C, HELLER R: In vivo gene delivery by electroporation. Adv. Drug Deify. Rev. (1999) 35:131–137.
  • VANBEVER R, PREAT VV: In vivo efficacy and safety of skin electroporation. Adv. Drug Deify. Rev. (1999) 35:77–88.
  • WELLS JM, LI LH, SEN A, JAHREIS GP,HUI SW: Electroporation-enhanced gene delivery in mammary tumors. Gene Ther. (2000) 7:541–547.
  • TANELIAN DL, BARRY MA, JOHNSTON SA, LE T, SMITH G: Controlled gene gun delivery and expression of DNA within the cornea. Biotechniques (1997) 23:484–488.
  • UDVARDI A, KUFFERATH I, GRUTSCH H, ZATLOUKAL K, VOLC-PLATZER B: Uptake of exogenous DNA via the skin. j Mol. Med. (1999) 77:744–750.
  • SATO H, HATTORI S, KAWAMOTO S et al.: In vivo gene gun-mediated DNA delivery into rodent brain tissue. Biochem. Biophys. Res. Commun. (2000) 270:163–170.
  • ROBBINS PD, GHIVIZZANI SC: Viral vectors for gene therapy. Pharmacol. Ther. (1998) 80:35–47.
  • STRAYER DS: Viral gene delivery. Expert Opin. Investig. Drugs (1999) 8:2159–2172.
  • WALTHER W, STEIN U: Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs (2000) 60:249–271.
  • KAY MA, GLORIOSO JC, NALDINI L: Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat. Med. (2001) 7:33–40.
  • PITARD B, AGUERRE O, AIRIAU M et al.: Virus-sized self-assembling lamellar complexes between plasmid DNA and cationic micelles promote gene transfer. Proc. Natl. Acad. Sci. USA (1997) 94:14412–14417.
  • CHONN A, CULLIS P: Recent advancesin liposome technologies and their applications for systemic gene delivery. Adv. Drug Deify. Rev. (1998) 30:73–83.
  • POUTON CW, SEYMOUR LW: Key issues in non-viral gene delivery. Adv. Drug Deify. Rev (1998) 34:3–19.
  • BALLY MB, HARVIE P, WONG FM, KONG S, WASAN EK, REIMER DL: Biological barriers to cellular delivery of lipid-based DNA carriers. Adv. Drug Deify. Rev. (1999) 38:291–315.
  • HOFLAND HE, SHEPHARD L, SULLIVAN SM: Formation of stable cationic lipid/DNA complexes for gene transfer. Proc. Natl. Acad. Sci. USA (1996) 93:7305–7309.
  • ANCHORDOQUY TJ, ALLISON SD, MOLINA MC, GIROUARD LG, CARSON TK: Physical stabilisation of DNA-based therapeutics. Drug Discov. Today (2001) 6:463–470.
  • FELGNER PL, BARENHOLZ Y, BEHR JP et al.: Nomenclature for synthetic gene delivery systems. Hum. Gene Ther. (1997) 8:511–512.
  • EASTMAN SJ, SIEGEL C, TOUSIGNANT J, SMITH AE, CHENG SH, SCHEULE RK: Biophysical characterization of cationic lipid: DNA complexes. Biochim. Biophys. Acta (1997) 1325:41–62.
  • WONG FM, REIMER DL, BALLY MB: Cationic lipid binding to DNA: characterization of complex formation. Biochemistry (1996) 35:5756–5763.
  • BATTERSBY BJ, GRIMM R, HUEBNER S, CEVC G: Evidence for three-dimensional interlayer correlations in cationic lipid-DNA complexes as observed by cryo-electron microscopy. Biochim. Biophys. Acta (1998) 1372:379–383.
  • HARRIES D, MAY S, GELBART WM, BEN-SHAUL A: Structure, stability, and thermodynamics of lamellar DNA-lipid complexes. Biophys. J. (1998) 75:159–173.
  • HUEBNER S, BATTERSBY BJ, GRIMM R, CEVC G: Lipid-DNA complex formation: reorganization and rupture of lipid vesicles in the presence of DNA as observed by cryoelectron microscopy. Biophys. J. (1999) 76:3158–3166.
  • FELGNER PL, GADEK TR, HOLM M et al.: Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA (1987) 84:7413–7417.
  • FELGNER PL, RINGOLD GM: Cationic liposome-mediated transfection. Nature (1989) 337:387–388.
  • MALONE RW, FELGNER PL, VERMA IM: Cationic liposome-mediated RNA transfection. Proc. Natl. Acad. Sci. USA (1989) 86:6077–6081.
  • BEHR JP: DNA strongly binds to micelles and vesicles containing lipopolyamines or lipointercalants. Tetrahedron Lett. (1986) 27:5861–5864.
  • BEHR JP, DEMENEIX B, LOEFFLER JP, PEREZ-MUTUL J: Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc. Natl. Acad. Sci. USA (1989) 86:6982–6986.
  • PINNADUWAGE P, SCHMITT L, HUANG L: Use of a quaternary ammonium detergent in liposome mediated DNA transfection of mouse L-cells. Biochim. Biophys. Acta (1989) 985:33–37.
  • LEVENTIS R, SILVIUS JR: Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles. Biochim. Biophys. Acta (1990) 1023:124–132.
  • GAO X, HUANG L: A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochim. Biophys. Acta (1991) 179:280–285.
  • WU GY, WU CH: Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. j Biol. Chem. (1987) 262:4429–4432.
  • WU GY, WU CH: Receptor-mediated genedelivery and expression in vivo. j Biol. Chem. (1988) 263:14621–14624.
  • WAGNER E, ZENKE M, COTTEN M, BEUG H, BIRNSTIEL ML: Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc. Natl. Acad. Sci. USA (1990) 87:3410–3414.
  • ZHOU XH, KLIBANOV AL, HUANG L: Lipophylic polylysines mediate efficient DNA transfection in mammalian cells.1745 Biochim. Biophys. Acta (1991) 1065:8–14.
  • KONSTANTINOVA ID, SEREBRENNIKOVA GA: Positively charged lipids: structure, methods of synthesis and applications. Russ. Chem. Rev (1996) 65:537–553.
  • LEE RJ, HUANG L: Lipidic vector systems for gene transfer. Grit. Rev Ther. Dug Carrier Syst. (1997) 14:173–206.
  • ZABNER J: Cationic lipids used in gene transfer. Adv. Dug Deify. Rev (1997) 27:17–28.
  • FELGNER PL: Nonviral strategies for gene therapy. Sci. Am. (1997) 276:102–106.
  • MILLER AD: Cationic liposomes for gene therapy. Angew. Chem. Int. Ed. (1998) 37:1768–1785.
  • TSENG WC, HUANG L: Liposome-based gene therapy. Pharm. Sci. Tech. Today (1998) 1:206–213.
  • REMY JS, ABDALLAH B, ZANTA MA, BOUSSIF O, BEHR JE DEMENEIX B: Gene transfer with lipospermines and polyethylenimines. Adv. Dug Deify. Rev. (1998) 30:85–95.
  • KABANOV AV, KABANOV VA: Interpolyelectrolyte and block ionomer complexes for gene delivery: physico-chemical aspects. Adv. Drug Deify. Rev (1998) 30:49–60.
  • KABANOV AV: Taking polycation gene delivery systems from in vitro to in vivo. Pharm. Sci. Tech. Today(1999) 2:365–372.
  • CHESNOY S, HUANG L: Structure and function of lipid-DNA complexes for gene delivery. Ann. Rev Biophys. Biomol Struct. (2000) 29:27–47.
  • MADSEN SK, MOONEY DJ: Delivering DNA with polymer matrices: application in tissue engineering and gene therapy. Pharm. Sci. Tech. Today (2000) 3:381–384.
  • ESFAND R, TOMALIA DA: Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov. Today (2001) 6:427–436.
  • NISHIKAWA M, HUANG L: Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum. Gene Ther. (2001) 12:861–870.
  • PEDROSO DE LIMA MC, SIMOES S, PIRES E FANECA H, DUZGUNES N: Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. Adv. Drug Deliv. Rev (2001) 47:277–294.
  • BYK G, SCHERMAN D: Novel cationiclipids for gene delivery and gene therapy. Expert Opin. Ther. Patents (1998) 8:1125–1141.
  • DEONARAIN MP: Ligand-targeted receptor-mediated vectors for gene delivery. Expert Opin. Ther. Patents (1998) 8:53–69.
  • REN T, LIU D: Synthesis of cationic lipids from 1,2,4-butanetriol. Tetrahedron Lett. (1999) 40:209–212.
  • REN T, LIU D: Synthesis of diether-linked cationic lipids for gene delivery. Bioorg. Med. Chem. Lett. (1999) 9:1247–1250.
  • REN T, SONG YK, ZHANG G, LIU D: Structural basis of DOTMA for its high intravenous transfection activity in mouse. Cone Ther. (2000) 7:764–768.
  • REN T, ZHANG G, SONG YK, LIU D: Synthesis and characterization of aromatic ring-based cationic lipids for gene delivery in vitro and in vivo. j Drug Targets (1999) 7:285–292.
  • GAO X, HUANG L: Cationic liposome-mediated gene transfer. Gene Ther. (1995) 2:710–722.
  • REMY JS, KICHLER A, MORDVINOV V, SCHUBER F, BEHR JP: Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses. Proc. Natl. Acad. Sci. USA (1995) 92:1744–1748.
  • KAWAKAMI S, FUMOTO S, NISHIKAWA M, YAMASHITA E HASHIDA M: In vivo gene delivery to the liver using novel galactosylated cationic liposomes. Pharm. Res. (2000) 17:306–313.
  • REN T, LIU D: Synthesis of targetable cationic amphiphiles. Tetrahedron Lett. (1999) 40:7621–7625.
  • BHATTACHARYA S, DILEEP PV: Synthesis of novel cationic lipids with oxyethylene spacers at the linkages between hydrocarbon chains and pseudoglyceryl backbone. Tetrahedron Lett. (1999) 40:8167–8171.
  • FELGNER JH, KUMAR R, SRIDHAR CN et al.: Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. _J. Biol. Chem. (1994) 269:2550–2561.
  • WHEELER CJ, FELGNER PL, TSAI YJ et al.: A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc. Natl. Acad. Sci. USA (1996) 93:11454–11459.
  • LE BOLC'H G, LEBRIS N, YAOUANC JJ, CLEMENT JC, DES ABBAYES H: Cationic phosphonolipids as non viral vectors for DNA transfection. Tetrahedron Lett. (1995) 36:6681–6684.
  • FLOCH V, DELEPINE P, GUILLAUME C et al: Systemic administration of cationic phosphonolipids/DNA complexes and the relationship between formulation and lung transfection efficiency. Biochim. Biophys. Acta (2000) 1464:95–103.
  • DELEPINE P, GUILLAUME C, FLOCH V et al.: Cationic phosphonolipids as nonviral vectors: in vitro and in vivo applications. j Pharm. Sci. (2000) 89:629–638.
  • FLOCH V, LEGROS N, LOISEL S et al: New biocompatible cationic amphiphiles derivative from glycine betaine: a novel family of efficient nonviral gene transfer agents. Biochem. Biophys. Res. Commun. (1998) 251:360–365.
  • FLOCH VV, LOISEL S, GUENIN E et al.: Cation substitution in cationic phosphonolipids: a new concept to improve transfection activity and decrease cellular toxicity. I Med. Chem (2000) 43:4617–4628.
  • GUILLAUME C, DELEPINE P, DROAL C, MONTIER T, TYMEN G, CLAUDE F: Aerosolization of cationic lipid-DNA complexes: lipoplex characterization and optimization of aerosol delivery conditions. Biochem. Biophys. Res. Commun. (2001) 286:464–471.
  • NAZIH A, CORDIER Y, BISCHOFF R, KOLBE HVJ, HEISSLER D: Synthesis and stability study of the new pentammonio lipid pcTG90, a gene transfer agent. Tetrahedron Lett. (1999) 40:8089–8091.
  • SCHUGHART K, BISCHOFF R, ALT HADJI D et al.: Effect of liposome-encapsulated clodronate pretreatment on synthetic vector-mediated gene expression in mice. Cone Ther. (1999) 6(3):448–453.
  • CHOI JS, LEE EJ, JANG HS, PARK JS: New cationic liposomes for gene transfer into mammalian cells with high efficiency and low toxicity. Bioconjug. Chem. (2001) 12:108–113.
  • REN T, ZHANG G, LIU F, LIU D: Synthesis and evaluation of vitamin D-based cationic lipids for gene delivery in vitro. Bioorg. Med. Chem. Lett. (2000) 10:891–894.
  • BESSODES M, DUBERTRET C, JASLING, SCHERMAN D: Synthesis and 1146Expert Opin. Ther. Patents (2001) 11(11) biological properties of new glycosidic cationic lipids for DNA delivery. Bioorg. Med. Chem. Lett. (2000) 10:1393–1395.
  • BYK G, DUBERTRET C, ESCRIOU V et al.: Synthesis, activity, and structure-activity relationship studies of novel cationic lipids for DNA transfer. j Med. Chem. (1998) 41:229–235.
  • TANG F, HUGHES JA: Introduction of adisulfide bond into a cationic lipid enhances transgene expression of plasmid DNA. Biochem. Biophys. Res. Commun. (1998) 242:141–145.
  • TANG E WANG W, HUGHES JA: Cationic liposomes containing disulfide bonds in delivery of plasmid DNA. I Lipid Res. (1999) 9:331–347.
  • TANG E HUGHES JA: Use of dithiodiglycolic acid as a tether for cationic lipids decreases the cytotoxicity and increases transgene expression of plasmid DNA in vitro. Bioconjug. Chem. (1999) 10:791–796.
  • BYK G, WETZER B, FREDERIC M et al.:Reduction-sensitive lipopolyamines as a novel nonviral gene delivery system for modulated release of DNA with improved transgene expression. I Med. Chem. (2000) 43:4377–4387.
  • WETZER B, BYK G, FREDERIC M et al.:Reducible cationic lipids for gene transfer. Biochem. (2001) 356:747–756.
  • HAWLEY-NELSON P, CICCARONE V, GEBEYEHU G, JESSEE J, FELGNER PL: Lipofectamine reagent: a new higher efficiency polycationic liposome transfection reagent. Focus (1993) 15:73–79.
  • FENJVES ES, SMITH J, ZARADIC S, TAICHMAN LB: Systemic delivery of secreted protein by grafts of epidermal keratinocytes: prospects for keratinocyte gene therapy. Hum. Gene Ther. (1994) 5:1241–1248.
  • FREDERIC M, SCHERMAN D, BYK G: Introduction of cyclic guanidines into cationic lipids for non-viral gene delivery. Tetrahedron Lett. (2000) 41:675–679.
  • SOLODIN I, BROWN CS, BRUNO MS et al.: A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery. Biochemistry (1995) 34:13537–13544.
  • MEEKEL AAP, WAGENAAR A, SMISTEROVA J et al.: Synthesis of pyridinium amphiphiles used for transfection and some characteristics of amphiphileMNA complex formation. Eur. Org. Chem. (2000):665–673.
  • HARRINGTON JJ, VAN BOKKELEN G, MAYS RW, GUSTASHAW K, WILLARD HF: Formation of de novo centromeres and construction of first-generation human artificial microchromosomes. Nat. Genet. (1997) 15:345–355.
  • SAFINYA CR: Structures of lipid-DNA complexes: supramolecular assembly and gene delivery. Curr. Opin Struct. Biol. (2001) 11:440–448.
  • STERNBERG B, SORGI FL, HUANG L: New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy. FEBS Lett (1994) 356:361–366.
  • COLLINS KD: Sticky ions in biological systems. Proc. Nati Acad. Sri. USA (1995) 92:5553–5557.
  • ABERLE AM, BENNETT MJ, MALONE RW, NANTZ MH: The counterion influence on cationic lipid-mediated transfection of plasmid DNA. Biochim. Biophys. Acta (1996) 1299:281–283.
  • COLLINS KD: Charge density-dependent strength of hydration and biological structure. Biophys. J (1997) 72:65–76.
  • BENNETT MJ, ABERLE AM, BALASUBRAMANIAM RP MALONE JG, MALONE RW, NANTZ MH: Cationic lipid-mediated gene delivery to murine lung: correlation of lipid hydration with in vivo transfection activity. I Med. Chem. (1997) 40:4069–4078.
  • ZUIDAM NJ, BARENHOLZ Y: Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecy1-7-hydroxycoumarin. Biochim. Biophys. Acta (1997) 1329:211–222.
  • FANG Y, YANG J: Two-dimensional condensation of DNA molecules on cationic lipid membranes. I Phys. Chem. B. (1997) 101:441–449.
  • SPINK CH, CHAIRES JB: Thermodinamics of the binding of a cationic lipid to DNA. j Am. Chem. Soc. (1997) 119:10920–10928.
  • SARAPUK J, KLESZCZYNSKA H, ROZYCKA-ROSZAK B: The role of counterions in the interaction of bifunctional surface active compounds with model membranes. Biochem. Mol. Biol. Int. (1998) 44:1105–1110.
  • SARAPUK J, KLESZCZYNSKA H, PERNAK J, KALEWSKA J, ROZYCKA-ROSZAK B: Influence of counterions on the interaction of pyridinium salts with model membranes. Z Naturforsch (1999) 54:952–955.
  • ZANTL R, BAICU L, ARTZNER F, SPRENGER I, RAPP G, RADLER JO: Thermotropic phase behavior of cationic lipid-DNA complexes compared to binary lipid mixtures. I Phys. Chem. B. (1999) 103:10300–10310.
  • HIRSCH-LERNER D, BARENHOLZ Y: Hydration of lipoplexes commonly used in gene delivery: follow-up by laurdan fluorescence changes and quantification by differential scanning calorimetry. Biochim. Biophys. Acta (1999) 1461:47–57.
  • BIRCHALL JC, KELLAWAY IW, MILLS SN: Physico-chemical characterisation and transfection efficiency of lipid-based gene delivery complexes. Int. I Pharm. (1999) 183:195–207.
  • PITARD B, OUDRHIRI N, VIGNERON JP et al.: Structural characteristics of supramolecular assemblies formed by guanidinium-cholesterol reagents for gene transfection. Proc. Natl. Acad. Sci. USA (1999) 96:2621–2626.
  • ROZYCKA-ROSZAK B, PRUCHNIK H: Effect of counterions on the influence of dodecyltrimethylammonium halides on thermotropic phase behaviour of phosphatidylcholine bilayers. Z Naturforsch (2000) 55c:240–244.
  • ROZYCKA-ROSZAK B, ZYLKA R, SARAPUK J: Hydration of alkylammonium salt micelles - influence of bromide and chloride counterions. Z Naturforsch (2000) 55c:413–417.
  • ISHIWATA H, SUZUKI N, ANDO S, KIKUCHI H, KITAGAWA T: Characteristics and biodistribution of cationic liposomes and their DNA complexes. I Control Release (2000) 69:139–148.
  • BHATTACHARYA S, HALDAR S: Interactions between cholesterol and lipids in bilayer membranes. Role of lipid headgroup and hydrocarbon chain-backbone linkage. Biochim. Biophys. Acta (2000) 1467:39–53.
  • EVEN-CHEN S, BARENHOLZ Y: DOTAP cationic liposomes prefer relaxed over supercoiled plasmids. Biochim. Biophys. Acta (2000) 1509:176–188.
  • SAKURAI F, INOUE R, NISHINO Yet al.: Effect of DNA/liposome mixing ratio 1747 Expert Op/n. Ther. Patents (2001) 11(11) on the physicochemical characteristics, cellular uptake and intracellular trafficking of plasmid DNA/cationic liposome complexes and subsequent gene expression. Control Release (2000) 66:255–269.
  • PECTOR V, BACKMANN J, MAES D, VANDENBRANDEN M, RUYSSCHAERT JM: Biophysical and structural properties of DNA.diC(14)-amidine complexes. Influence of the DNA/ lipid ratio. j. Biol. Chem. (2000) 275:29533–29538.
  • KIKUCHI IS, CARMONA-RIBEIRO AM: Interactions between DNA and synthetic cationic liposomes. j. Phys. Chem. B. (2000) 104:2829–2835.
  • WANGEREK LA, DAHL HH, SENDEN TJ et al.: Atomic force microscopy imaging of DNA-cationic liposome complexes optimised for gene transfection into neuronal cells. j. Gene Med. (2001) 3:72–81.
  • STEWART L, MAN VELL M, HILLERY E et al.: Physico-chemical analysis of cationic liposome-DNA complexes (lipoplexes) with respect to in vitro and in vivo gene delivery efficiency. j. Chem. Soc. Perkin. Trans. (2001) 2.624–632.
  • LOBO BA, DAVIS A, KOE G, SMITH JG, MIDDAUGH CR: Isothermal titration calorimetric analysis of the interaction between cationic lipids and plasmid DNA. Arch. Biochem. Biophys. (2001) 386:95–105.
  • FARHOOD H, SERBINA N, HUANG L: The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta (1995) 1235:289–295.
  • BHATTACHARYA S, HALDAR S: The effects of cholesterol inclusion on the vesicular membranes of cationic lipids. Biochim. Biophys. Acta (1996) 1283:21–30.
  • ZUIDAM NJ, BARENHOLZ Y: Electrostatic and structural properties of complexes involving plasmid DNA and cationic lipids commonly used for gene delivery. Biochim. Biophys. Act. (1998) 1368:115–128.
  • KOYNOVA R, CAFFREY M: Phases and phase transitions of the phosphatidylcholines. Biochim. Biophys. Acta (1998) 1376:91–145.
  • ZUIDAM NJ, HIRSCH-LERNER D, MARGULIES S, BARENHOLZ Y: Lamellarity of cationic liposomes and mode of preparation of lipoplexes affect transfection efficiency. Biochim. Biophys. Acta (1999) 1419:207–220.
  • AUDOUY S, MOLEMA G, DE LEIJ L, HOEKSTRA D: Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability. j. Gene Med. (2000) 2:465–476.
  • MATSUI H, PANS: Distribution of DNA in cationic liposome complexes probed by Raman microscopy. Langmuir (2001) 17:571–573.
  • KERNER M, MEYUHAS O, HIRSCH-LERNER D, ROSEN LJ, MIN Z, BARENHOLZ Y: Interplay in lipoplexes between type of pDNA promoter and lipid composition determines transfection efficiency of human growth hormone in NIH3T3 cells in culture. Biochim. Biophys. Acta (2001) 1532:128–136.
  • ZUIDAM NJ, BARENHOLZ Y, MINSKY A: Chiral DNA packaging in DNA-cationic liposome assemblies. FEBS Lett. (1999) 457:419–422.
  • MEIDAN VM, COHEN JS, AMARIGLIO N, HIRSCH-LERNER D, BARENHOLZ Y: Interaction of oligonucleotides with cationic lipids: the relationship between electrostatics, hydration and state of aggregation. Biochim. Biophys. Acta (2000) 1464:251–261.
  • BERGAN D, GALBRAITH T, SLOANE DL: Gene transfer in vitro and in vivo by cationic lipids is not significantly affected by levels of supercoiling of a reporter plasmid. Pharm. Res. (2000) 17:967–973.
  • HIRSCH-LERNER D, BARENHOLZ Y: Probing DNA-cationic lipid interactions with the fluorophore trimethylammonium diphenyl-hexatriene (TMADPH). Biochim. Biophys. Acta (1998) 1370:17–30.
  • WONG FM, BALLY MB, BROOKS DE: Electrostatically mediated interactions between cationic lipid-DNA particles and an anionic surface. Arch. Biochem. Biophys. (1999) 366:31–39.
  • SON la, TKACH D, HALL KJ: Efficient in vivo gene delivery by the negatively charged complexes of cationic liposomes and plasmid DNA. Biochim. Biophys. Acta (2000) 1468:6–10.
  • LEE H, WILLIAMS SK, ALLISON SD, ANCHORDOQUY TJ: Analysis of self-assembled cationic lipid-DNA gene carrier complexes using flow field-flow fractionation and light scattering. Anal. Chem. (2001) 73:837–843.
  • SEMPLE SC, KLIMUK SK, HARASYM TO et al.: Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. Biochim. Biophys. Acta (2001) 1510:152–166.
  • RASPAUD E, PITARD B, DURAND D et al.: Polymorphism of DNA/multi-cationic Lipid complexes driven by temperature and salts. j. Phys. Chem. B. (2001) 105:5291–5297.
  • BOUKHNIKACHVILI T, AGUERRE-CHARIOL O, AIRIAU M, LESIEUR S, OLLI VON M, VACUS J: Structure of in-serum transfecting DNA-cationic lipid complexes. FEBS Lett. (1997) 409:188–194.
  • MEENIKOV SM, LINDMAN B: Solubilisation of DNA-cationic lipid complexes in hydrophobic solvents. A single molecule visualization by fluorescence microscopy. Langmuir (1999) 15:1923–1928.
  • GERSHON H, GHIRLANDO R, GUTTMAN SB, MINSKY A: Mode of formation and structural features of DNA-cationic liposome complexes used for transfection. Biochemistry (1993) 32:7143–7151.
  • MOK KW, CULLIS PR: Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA. Biophys. (1997) 73:2534–2545.
  • REIMER DL, ZHANG Y, KONG S, WHEELER JJ, GRAHAM RW, BALLY MB: Formation of novel hydrophobic complexes between cationic lipids and plasmid DNA. Biochemistry (1995) 34:12877–12883.
  • WAGNER K, HARRIES D, MAY S, KAHL V, RADLER JO, BEN-SHAUL A: Direct evidence for counterion release upon cationic lipid-DNA condensation. Langmuir (2000) 16:303–306.
  • SAMUNI AM, CROMMELIN DJA, ZUIDAM NJ, BARENHOLZ Y: Differential scanning calorimetry - a tool to assess physical and chemical alterations in liposomes. j Therm. Anal. Calothn. (1998) 51:37–48.
  • BHATTACHARYA S, MANDAL SS: Interaction of surfactants with DNA. Role of hydrophobicity and surface charge on intercalation and DNA melting. Biochim. Biophys. Acta (1997) 1323:29–44.
  • ZUIDAM NJ, BARENHOLZ Y: Characterization of DNA-lipid complexes commonly used for gene delivery. Int. Pharm. (1999) 183:43–46.
  • RADLER JO, KOLTOVER I, SALDITT T, SAFINYA CR: Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes [see comments]. Science (1997) 275:810–814.
  • LASIC DD, STREY H, STUART MCA, POD GORNIK R, FREDERIC PM: The structure of DNA-liposome complexes. Am. Chem. Soc. (1997) 119:832–833.
  • KOLTOVER I, SALDITT T, RADLER JO, SAFINYA CR: An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science (1998) 281:78–81.
  • RADLER JO, KOLTOVER I, JAMIESON A, SALDITT T, SAFINYA CR: Structure and interfacial aspects of self-assembled cationic lipid-DNA gene carrier complexes. Langmuir (1998) 14:4272–4283.
  • KOLTOVER I, WAGNER K, SAFINYA CR: DNA condensation in two dimensions. Proc. Natl. Acad. Li. USA (2000) 97:14046–14051.
  • THOMSON NH, COLLIN I, DAVIES MC et al.: Atomic force microscopy of cationic liposomes. Langmuir (2000) 16:4813–4818.
  • DAN N: The structure of DNA complexes with cationic liposomes-cylindrical or flat bilayers? Biochim. Biophys. ActaActa (1998) 1369:34–38.
  • GUSTAFSSON J, ARVIDSON G, KARLSSON G, ALMGREN M: Complexes between cationic liposomes and DNA visualized by cryo-TEM. Biochim. Biophys. Acta (1995) 1235:305–312.
  • LITZINGER DC, HUANG L: Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications. Biochim. Biophys. Acta (1992) 1113:201–227.
  • LIN AJ, SLACK NL, AHMAD A et al: Structure and structure-function studies of lipicliplasmid DNA complexes. j Drug Targets (2000) 8:13–27.
  • ZHOU X, HUANG L: DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim. Biophys. Acta (1994) 1189:195–203.
  • WROBEL I, COLLINS D: Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim. Biophys. Acta (1995) 1235:296–304.
  • SIMBERG D, HIRSCH-LERNER D, NISSIM R, BARENHOLZ Y: Comparison of different commercially available cationic lipid-based transfection kits. j Liposome Res. (2000) 10:1–13.
  • LASIC DD: Liposomes in Gene Delivery:. CRC Press, Boca Raton, (1997).
  • YANG JP, HUANG L: Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. Gene Ther. (1997) 4:950–960.
  • LI S, HUANG L: Nonviral gene therapy: promises and challenges. Gene Ther. (2000) 7:31–34.
  • DA CRUZ MT, SIMOES S, PIRES PP, NIR S, DE LIMA MC: Kinetic analysis of the initial steps involved in lipoplex-cell interactions: effect of various factors that influence transfection activity. Biochim. Biophys. Acta (2001) 1510:136–151.
  • BRAGONZI A, DINA G, VILLA A et al: Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther. (2000) 7:1753–1760.
  • TAKAKURA Y, NISHIKAWA M, YAMASHITA F, HASHIDA M: Development of gene drug delivery systems based on pharmacokinetic studies. Eur. Pharm. Li. (2001) 13:71–76.
  • UYECHI LS, GAGNE L, THURSTON G, SZOKA FC, Jr.: Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components. Gene Ther. (2001) 8:828–836.
  • MANN MJ: Gene therapy for peripheral arterial disease. Mal Med. Today (2000) 6:285–291.
  • JAFFE A, JUDD D, RATCLIFFE C et al: Cationic lipid-mediated gene transfer to the growing murine and human airway. Gene Ther. (2000) 7:273–278.
  • MADRY H, RESZKA R, BOHLENDER J, WAGNER J: Efficacy of cationic liposome-mediated gene transfer to mesangial cells in vitro and in vivo. j Mal Med. (2001) 79:184–189.
  • KOEHLER DR, HANNAM V, BELCASTRO R et al: Targeting transgene expression for cystic fibrosis gene therapy. Mal Ther. (2001) 4:58–65.
  • GOWDAK LH, POLIAKOVA L, LI Z, GROVE R, LAKATTA EG, TALAN M: Induction of angiogenesis by cationic lipid-mediated VEGF165 gene transfer in the rabbit ischemic hindlimb model. j Vase. Surg. (2000) 32:343–352.
  • HELLGREN I, DRVOTA V, PIEPER R et al.: Highly efficient cell-mediated gene transfer using non-viral vectors and FuGene6: in vitro and in vivo studies. Cell Mal Life Sci. (2000) 57:1326–1333.
  • ROBBINS PD (Ed.): Gene Therapy Protocols. Humana Press, Totowa, USA (1997).
  • MOHR L, YOON SK, EASTMAN SJ et al.: Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice. Hum. Gene Ther. (2001) 12:799–809.
  • ENNIST DL: Gene therapy for lung disease. Trends Pharm. ScL (1999) 20:260–266.
  • CLARK PR, STOPECK AT, FERRARI M, PARKER SE, HERSH EM: Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA. Cancer Gene Ther. (2000) 7:853–860.
  • SAITO H, NAKAMURA H, KATO S et al.: Percutaneous in vivo gene transfer to the peripheral lungs using plasmid-liposome complexes. Am. I Physiol Lung Cell Mal Physiol (2000) 279:L651–657.
  • HECKER JG, HALL LL, IRION VR: Nonviral gene delivery to the lateral ventricles in rat brain: initial evidence for widespread distribution and expression in the central nervous system. Mal Ther. (2001) 3:375–384.
  • COSTANTINI LC, BAKOWSKA JC, BREAKEFIELD XO, ISACSON O: Gene therapy in the CNS. Gene Ther. (2000) 7:93–109.
  • MADRY H, TRIPPEL SB: Efficient lipid-mediated gene transfer to articular chondrocytes. Gene Ther. (2000) 7:286–291.
  • SPIRITO F, MENEGUZZI G, DANOS O, MEZZINA M: Cutaneous gene transfer and therapy: the present and the future. Gene Med. (2001) 3:21–31.
  • PLEYER U, GROTH D, HINZ B et al.: Efficiency and toxicity of liposome-mediated gene transfer to corneal endothelial cells. Exp. Eye Res. (2001) 73:1–7.
  • TAN PH, KING WJ, CHEN D et al: Transferrin receptor-mediated gene transfer to the corneal endothelium. Transplantation (2001) 71:552–560.
  • STRIBLING R, BRUNETTE E, LIGGITT D, GAENSLER K, DEBS R: Aerosol gene delivery in vivo. Proc. Natl. Acad. Sci. USA (1992) 89:11277-11281.1749
  • DAVIES JC, GEDDES DM, ALTON EW: Prospects for gene therapy for cystic fibrosis. Mol. Med. Today (1998) 4:292–299.
  • RUIZ FE, CLANCY JP, PERRICONE MA et al.: A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum. Gene Ther. (2001) 12:751–761.
  • ESCRIOU V, CIOLINA C, LACROIX F, BYK G, SCHERMAN D, WILS P: Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. Biochim. Biophys. Acta (1998) 1368:276–288.
  • SAKURAI F, NISHIOKA T, SAITO H et al.: Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid. Gene Ther. (2001) 8:677–686.
  • LI S, TSENG WC, STOLZ DB, WU SP, WATKINS SC, HUANG L: Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther. (1999) 6:585–594.
  • HASHIDA M, MAHATO RI, KAWABATA K, MIYAO T, NISHIKAWA M, TAKAKURA Y: Pharmacokinetics and targeted delivery of proteins and genes. Control Release (1996) 41:91–97.
  • BAILEY AL, CULLIS PR: Membrane fusion with cationic liposomes: effects of target membrane lipid composition. Biochemistry (1997) 36:1628–1634.
  • HAFEZ IM, MAURER N, CULLIS PR: On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther. (2001) 8:1188–1196.
  • ROSS PC, HUI SW: Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Ther. (1999) 6:651–659.
  • JANOFF AS: Liposomes: Rational Design New York, Basel, Marcel Dekker, (1999).
  • MISLICK KA, BALDESCHWIELER JD: Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. USA (1996) 93:12349–12354.
  • LABAT-MOLEUR ESTEFFAN AM, BRISSON C et al.: An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther. (1996) 3:1010–1017.
  • MOUNKES LC, ZHONG W, CIPRES-PALACIN G, HEATH TD, DEBS RJ: Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. j Biol. Chem. (1998) 273:26164–26170.
  • ZABNER J, FASBENDER AJ, MONINGER T, POELLINGER KA, WELSH MJ: Cellular and molecular barriers to gene transfer by a cationic lipid. Biol. Chem. (1995) 270:18997–19007.
  • ZELPHATI O, SZOKA FC, JR.: Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids. Pharm. Res. (1996) 13:1367–1372.
  • FRIEND DS, PAPAHADJOPOULOS D, DEBS RJ: Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. Biochim. Biophys. Acta (1996) 1278:41–50.
  • EL OUAHABI A, THIRY M, PECTOR V, FUKS R, RUYSSCHAERT JM, VANDENBRANDEN M: The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids. FEBS Lett. (1997) 414:187–192.
  • COLIN M, MAURICE M, TRUGNAN G et al.: Cell delivery, intracellular trafficking and expression of an integrin-mediated gene transfer vector in tracheal epithelial cells. Gene Ther. (2000) 7:139–152.
  • MATSUI H, JOHNSON LG, RANDELL SH, BOUCHER RC: Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells. _J. Biol. Chem. (1997) 272:1117–1126.
  • SIMOES S, SLEPUSHKIN V, PIRES P, GASPAR R, PEDROSO DE LIMA MC, DUZGUNES N: Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum. Biochim. Biophys. Acta (2000) 1463:459–469.
  • KAWAKAMI S, SATO A, NISHIKAWA M, YAMASHITA F, HASHIDA M: Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther. (2000) 7:292–299.
  • VAN DER WOUDE I, VISSER HW, TER BEEST MB et al.: Parameters influencing the introduction of plasmid DNA into cells by the use of synthetic amphiphiles as a carrier system. Biochim. Biophys. Acta (1995) 1240:34–40.
  • WATTIAUX R, JADOT M, WARNIER-PIROTTE MT, WATTIAUX-DE CONINCK S: Cationic lipids destabilize lysosomal membrane in vitro. FEBS Lett. (1997) 417:199–202.
  • XU Y, SZOKA FC, Jr.: Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry (1996) 35:5616–5623.
  • ZELPHATI O, SZOKA FC, Jr.: Mechanism of oligonucleotide release from cationic liposomes. Proc. Nati Acad. Sci. USA (1996) 93:11493–11498.
  • BALASUBRAMANIAM RE BENNETT MJ, ABERLE AM, MALONE JG, NANTZ MH, MALONE RW: Structural and functional analysis of cationic transfection lipids: the hydrophobic domain. Gene Ther. (1996) 3:163–172.
  • HAFEZ IM, ANSELL S, CULLIS PR: Tunable pH-sensitive liposomes composed of mixtures of cationic and anionic lipids. Biophys. J. (2000) 79:1438–1446.
  • BRISSON M, HUANG L: Liposomes: Conquering the nuclear barrier. Curr. Opin. Mol. Ther. (1999) 1:140–146.
  • NAKANISHI M, AKUTA T, NAGOSHI E, EGUCHI A, MIZUGUCHI H, SENDA T: Nuclear targeting of DNA. Eur. Pharm. Sci. (2001) 13:17–24.
  • CAPECCHI MR: High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell (1980) 22:479–488.
  • LECHARDEUR D, SOHN KJ, HAARDT M et al.: Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther. (1999) 6:482–497.
  • BENNETT CF, CHIANG MY, CHAN H, SHOEMAKER JE, MIRABELLI CK: Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. (1992) 41:1023–1033.
  • CHIN DJ, GREEN GA, ZON G, SZOKA FC, Jr., STRAUBINGER RM: Rapid nuclear accumulation of injected oligodeoxyribonucleotides. New Biol. (1990) 2:1091–1100.
  • STOFFLER D, FAHRENKROG B, AEBI U: The nuclear pore complex: from molecular architecture to functional dinamics. Curr. Opin Cell Biol. (1999) 11:391–401.
  • LANG I, SCHOLZ M, PETERS R: Molecular mobility and nucleocytoplasmic flux in hepatoma cells. j Cell Biol. (1986) 102:1183–1190.
  • ADAM SA: Transport pathways of macromolecules between the nucleus and 1750 Expert Op/n. Ther. Patents (2001) 11(11) the cytoplasm. Curr. Opin. Cell Biol. (1999) 11:402–406.
  • ZANTA MA, BELGUISE-VALLADIER P, BEHR JP: Gene delivery: A single nuclear localisation signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Nati Acad. Sci. USA (1999) 96:91–96.
  • KANEDA Y, IWAI K, UCHIDA T: Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science (1989) 243:375–378.
  • ARONSOHN Al, HUGHES JA: Nuclear localisation signal peptides enhance cationic liposome-mediated gene therapy. I Drug Targets (1997) 5:163–169.
  • CSERMELY P, SCHNAIDER T, SZANTO I: Signalling and transport through the nuclear membrane. &edam. Biophys. Acta (1995) 1241:425–452.
  • BRANDEN LJ, MOHAMED AJ, SMITH CI: A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA. Nat. Biatechnol. (1999) 17:784–787.
  • SUBRAMANIAN A, RANGANATHAN P, DIAMOND SL: Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells. Nat. Blot-ea-mai (1999) 17:873–877.
  • HAGSTROM JE, SEBESTYEN MG, BUDKER V, LUDTKE JJ, FRITZ JD, WOLFF JA: Complexes of non-cationic liposomes and histone H1 mediate efficient transfection of DNA without encapsulation. Biochim. Biophys. Acta (1996) 1284:47–55.
  • HABERLAND A, KNAUS T, ZAITSEV SV et al.: Histone H1-mediated transfection: serum inhibition can be overcome by Ca2+ ions. Pharm. Res. (2000) 17:229–235.
  • SCHWARTZ B, IVANOV MA, PITARD B et al.: Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo. Gene Ther. (1999) 6:282–292.
  • DEAN DA: Import of plasmid DNA into the nucleus is sequence specific. Exp. Cell Res. (1997) 230:293–302.
  • MORTIMER I, TAM E MACLACHLAN I, GRAHAM RW, SARAVOLAC EG, JOSHI PB: Cationic lipid-mediated transfection of cells in culture requires mitotic activity. Gene Ther. (1999) 6:403–411.
  • BRUNNER S, SAUER T, CAROTTA S, COTTEN M, SALTIK M, WAGNER E: Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther. (2000) 7:401–407.
  • Summary Table: Human Gene Therapy Protocols: Hum. Gene Ther. (2001) 12(12):1585.
  • ANWER K, MEANEY C, KAO G et al.: Cationic lipid-based delivery system for systemic cancer gene therapy. Cancer Gene Ther. (2000) 7:1156–1164.
  • ANWER K, KAO G, PROCTOR B, ROLLAND A, SULLIVAN S: Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions. j Drug Targets (2000) 8:125–135.
  • SPACK EG, SORGI FL: Developing non-viral DNA delivery systems for cancer and infectious disease. Drug Discov. Today (2001) 6:186–197.
  • GEDDES D, ALTON E: Cystic fibrosis clinical trials. Adv. Drug Deify. Rev (1998) 30:205–217.
  • DAVIES JC, GEDDES DM, ALTON EWFW: Prospects for gene therapy in lung disease. Curr. Opin. Pharmacy]. (2001) 1: 272–277.
  • SCHOLL FG, SEN L, DRINKWATER DC et al.: Effects of human tissue plasminogen gene transfer on allograft coronary atherosclerosis. j Heart Lung Transplant (2001) 20:322–329.
  • ABUL-HASSAN K, WALMSLEY R, BOULTON M: Optimisation of non-viral gene transfer to human primary retinal pigment epithelial cells. Curr. Eye Res. (2000) 20:361–366.
  • BARENHOLZ Y: Liposome application: problems and prospects. Curr. Opin. Coll. Interf Sri. (2001) 6:66–77.
  • MCLACHLAN G, STEVENSON BJ, DAVIDSON DJ, PORTEOUS DJ: Bacterial DNA is implicated in the inflammatory response to delivery of DNA/ DOTAP to mouse lungs. Gene Ther. (2000) 7:384–392.
  • LOISEL S, LE GALL C, DOUCET L, FEREC C, FLOCH V: Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum. Gene Ther. (2001) 12:685–696.
  • NAGAHIRO I, MORA BN, BOASQUEVISQUE CH, SCHEULE RK, PATTERSON GA: Toxicity of cationic liposome-DNA complex in lung isografts. Transplantation (2000) 69:1802–1805.
  • TAN Y, LIU F, LI Z, LI S, HUANG L: Sequential injection of cationic liposome and plasmid DNA effectively transfects the lung with minimal inflammatory toxicity. Mal. Ther. (2001) 3:673–682.
  • LEHN P, FABREGA S, OUDRHIRI N, NAVARRO J: Gene delivery systems: Bridging the gap between recombinant viruses and artificial vectors. Adv. Drug Deily Rev (1998) 30:5–11.
  • BLESSING T, REMY JS, BEHR JP: Monomolecular collapse of plasmid DNA into stable virus-like particles. Proc. Natl. Acad. Sci. USA (1998) 95:1427–1431.
  • GAO X, HUANG L: Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry (1996) 35:1027–1036.
  • SORGI FL, BHATTACHARYA S, HUANG L: Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther. (1997) 4:961–968.
  • LI S, HUANG L: In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. (1997) 4:891–900.
  • LI S, RIZZO MA, BHATTACHARYA S, HUANG L: Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther. (1998) 5:930–937.
  • LEONE P, JANSON CG, BILIANUK L et Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease. Ann. Neural (2000) 48: 27–38.
  • MURRAY KD, ETHERIDGE CJ, SHAH SI et al.: Enhanced cationic liposome-mediated transfection using the DNA-binding peptide mu (mu) from the adenovirus core. Gene Ther. (2001) 8:453–460.

Websites

  • Clinical trial internet site. www.wiley.co.uld wileychi/genmed/clinical/(Charts and Statistics), last updated september 2001.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.